Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis

Published:2023-08-09 Issue:3 Volume:23 Page:197-210
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Tong Xinyu,Shen Lijuan^ORCID,Zhou Xiaomin,Wang Yudan,Chang Sheng,Lu Shu

Funder

Biological Network Integration Regulatory Mechanism of Linggui Yangxin Decoction in the Treatment of Dilated Cardiomyopathy

The Molecular Mechanism of Anti-pyroptosis of Shenqi Yangxin Decoction to Ameliorate Dilated Cardiomyopathy by Regulating DNA Methylation Involved in DNMT1

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-023-00435-5.pdf

Reference90 articles.

1. Pelliccia A, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):19–33.

2. Bozkurt B, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579–646.

3. Ciarambino T, et al. Cardiomyopathies: an overview. Int J Mol Sci. 2021;22(14):7722.

4. Reichart D, et al. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature. J Intern Med. 2019;286(4):362–72.

5. Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev. 2022;27(4):1173–91.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure With Improved Ejection Fraction: Prevalence, Predictors, and Guideline-Directed Medical Therapy;Cureus;2024-06-06

2. Analysis of post-market adverse events of ivabradine: a real-world study base on FAERS database;2024-06-06